Parallel Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$340K Buy
1,184
+185
+19% +$53.2K 0.01% 775
2025
Q1
$308K Sell
999
-91
-8% -$28K 0.01% 769
2024
Q4
$385K Buy
1,090
+30
+3% +$10.6K 0.01% 665
2024
Q3
$380K Buy
1,060
+123
+13% +$44.1K 0.01% 671
2024
Q2
$298K Buy
937
+144
+18% +$45.9K 0.01% 716
2024
Q1
$182K Buy
793
+63
+9% +$14.5K ﹤0.01% 891
2023
Q4
$161K Sell
730
-43
-6% -$9.46K ﹤0.01% 904
2023
Q3
$175K Buy
773
+61
+9% +$13.8K 0.01% 837
2023
Q2
$157K Buy
712
+182
+34% +$40.2K 0.01% 887
2023
Q1
$119K Buy
530
+50
+10% +$11.2K ﹤0.01% 979
2022
Q4
$133K Buy
480
+23
+5% +$6.4K 0.01% 871
2022
Q3
$96K Sell
457
-6
-1% -$1.26K ﹤0.01% 986
2022
Q2
$109K Buy
463
+14
+3% +$3.3K 0.01% 922
2022
Q1
$79K Sell
449
-180
-29% -$31.7K ﹤0.01% 1076
2021
Q4
$136K Buy
629
+20
+3% +$4.32K 0.01% 887
2021
Q3
$112K Buy
609
+22
+4% +$4.05K ﹤0.01% 925
2021
Q2
$105K Sell
587
-92
-14% -$16.5K ﹤0.01% 917
2021
Q1
$114K Buy
679
+89
+15% +$14.9K 0.01% 829
2020
Q4
$90K Buy
590
+175
+42% +$26.7K ﹤0.01% 835
2020
Q3
$42K Sell
415
-231
-36% -$23.4K ﹤0.01% 1117
2020
Q2
$78K Buy
646
+343
+113% +$41.4K 0.01% 864
2020
Q1
$28K Sell
303
-44
-13% -$4.07K ﹤0.01% 1170
2019
Q4
$31K Buy
347
+271
+357% +$24.2K ﹤0.01% 1210
2019
Q3
$6K Sell
76
-204
-73% -$16.1K ﹤0.01% 1868
2019
Q2
$22K Sell
280
-422
-60% -$33.2K ﹤0.01% 1235
2019
Q1
$82K Buy
702
+69
+11% +$8.06K 0.01% 668
2018
Q4
$68K Sell
633
-546
-46% -$58.7K 0.01% 658
2018
Q3
$151K Buy
1,179
+359
+44% +$46K 0.02% 472
2018
Q2
$92K Buy
820
+734
+853% +$82.4K 0.01% 561
2018
Q1
$10K Sell
86
-146
-63% -$17K ﹤0.01% 1284
2017
Q4
$34K Buy
232
+10
+5% +$1.47K 0.01% 831
2017
Q3
$27K Hold
222
﹤0.01% 898
2017
Q2
$29K Sell
222
-24
-10% -$3.14K 0.01% 871
2017
Q1
$30K Buy
246
+164
+200% +$20K 0.01% 812
2016
Q4
$12K Buy
+82
New +$12K ﹤0.01% 1053